BCDA 241115 7.50C (BCDA241115C7500) Stock Options, News & Quotes

Account Info

Log Out

US OptionsDetailed Quotes

BCDA241115C7500

Watchlist

0.00
0.000.00%

15min DelayTrading Nov 7 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

BioCardia to Host Q3 2024 Corporate Update and Financial Results Conference Call on November 13, 2024
GlobeNewswireNov 6 07:00 ET
Express News | HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target
BenzingaOct 28 11:18 ET
BioCardia Analyst Ratings
BenzingaOct 28 11:14 ET · Ratings
Promising Outlook for BioCardia With Advancements in CardiAMP HF Program and Personalized Treatment Approach
TipRanksOct 28 10:55 ET
BioCardia Completes Last Protocol Specified Follow-up Visit in CardiAMP HF
TipRanksOct 28 09:10 ET
Express News | BioCardia Inc - Results on Track for Top Line Release in Q1 2025
ReutersOct 28 09:00 ET

Comments

Jaguar8

Oct 28 21:11

Remember Top Line Data 1Q 2025

$BioCardia (BCDA.US)$

Jaguar8

Oct 28 08:01

NEWS

$BioCardia (BCDA.US)$
BioCardia Completes Phase III Randomized Double-Blind Controlled Trial of Autologous Cell Therapy for Ischemic Heart Failure
BioCardia has completed its Phase III CardiAMP HF trial, a randomized, double-blind, placebo-controlled study evaluating the CardiAMP Cell Therapy System for heart failure treatment. The trial enrolled 125 patients across 18 US hospitals, with 115 patients randomized 3:2 between treatment and control groups. The therapy, which received FDA Breakth...

Boxman

Sep 8 20:00

Here too!

$BioCardia (BCDA.US)$ same unregistered brokerage

104750472

Aug 30 07:06

$BioCardia (BCDA.US)$ 3$ offering yall

Trytosaveabit

Aug 30 07:04

$BioCardia (BCDA.US)$ BioCardia Announces Pricing of Upsized $7.2 Million Public Offering Priced at-the-Market Under Nasdaq Rules